SCHEMBL11301404

SCHEMBL11301404

O=C(NO)c1ccc(N(c2cccc(Oc3ccccc3)c2)C2CCNC2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 7/20 0.47
▸ NPC1 O15118 1/20 0.41
▸ HDAC6 Q9UBN7 6/20 0.41
▸ HDAC1 Q13547 4/20 0.41
▸ PKM P14618 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MMP1 P03956 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ RIPK1 Q13546 1/20 0.36
▸ MMP2 P08253 1/20 0.36
▸ MMP7 P09237 1/20 0.36
▸ MMP9 P14780 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ NR1H4 Q96RI1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297519 0.93 HDAC6 (0.43) HDAC8NPC1HDAC6HDAC1KDM4E
SCHEMBL11297424 0.89 HDAC1 (0.43) HDAC8NPC1HDAC6HDAC1ALDH1A1
SCHEMBL11297369 0.87 HDAC6 (0.40) HDAC8NPC1HDAC6HDAC1KDM4E
SCHEMBL11296174 0.87 HDAC8 (0.44) HDAC8NPC1HDAC6HDAC1KMT2A
SCHEMBL11304336 0.84 HDAC6 (0.42) HDAC8HDAC6HDAC1MMP13
SCHEMBL11302647 0.83 HDAC6 (0.43) HDAC8NPC1HDAC6HDAC1KMT2A
SCHEMBL11298752 0.83 HDAC8 (0.42) HDAC8HDAC6HDAC1
SCHEMBL11297505 0.82 HDAC8 (0.37) HDAC8NPC1HDAC6HDAC1KMT2A
SCHEMBL11300469 0.82 HDAC6 (0.47) HDAC8HDAC6HDAC1KMT2AMEN1
SCHEMBL11301397 0.81 HDAC1 (0.39) HDAC8HDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback